MedTech SuperConnector’s Post

📣We have a few remaining seats for neuromodulators in training or early in autonomous practice: Our virtual speed mentorship program facilitates enlightening discussions in a small group ‘speed mentorship’ format’, covering a spectrum of topics, including implantable technologies, best practices, clinical management, and career development in neuromodulation. Topics and Mentors: *️⃣ Things I wished I’d known in setting up a neuromodulation service - Marc Russo, MBBS, DA (UK), FANZCA, FFPMFANZCA *️⃣ Pre-operative assessments/checks to minimise complications - Stana Bojanic, BSc, MB BS, FRCS (SN) *️⃣ How to set up a team in your Neuromodulation service - Magdalena Anitescu, MD, PhD *️⃣ How to kickstart a publication profile - Lisa Goudman, PhD *️⃣ How to approach scs, pns, drg - Ganesan Baranidharan, FRCA, FCARCSI, FFPMRCA, PG Dip (Anaesthesia) *️⃣ How to get involved in clinical research - Kliment Gatzinsky MD, PhD *️⃣ Getting the most out of your Functional Fellowship - Kiran Patel, MD We look forward to seeing you there! Register: https://lnkd.in/gfwU7rNN

"Why strive to place MLS into research? My answer is, because the patients deserve quality results." In ASCLS Today, Adilene Olvera describes her Doctor of Clinical Laboratory Science (#DCLS) research project in which she created an informational video about the MLS field, and why she is passionate about #MedicalLaboratory professionals being involved in research. #IamASCLS #LaboratoryMedicine Read here: https://lnkd.in/g29pYC2Z

Northern Kentucky is quickly establishing itself as an innovative center for biomedical research, development, and production. From 2014-2019, employment in biomedical industries in the region grew by 82%, and employment in life sciences is projected to grow a further 49.1% from 2020-2025. Learn more about this industry, and the biomedical companies that call Northern Kentucky home, in this article: https://bit.ly/4g9fddt

This is optimal.

Elaf Ghoneim talks helping people, loving science, and pursuing a career in medicine in the Beckman Friday Feature. Recent University of Kentucky graduate, Elaf Ghoneim, was born and raised in Lexington, Kentucky. Her family, originally from Libya, established a tight-knit, community-oriented home that emphasized the importance of service and advocacy. This upbringing cultivated her self-assuredness and instilled a deep sense of purpose, nurturing her two great passions: helping people and a love of science. Ghoneim aspires to pursue a career in medicine, where she hopes to make a meaningful impact in her community. “In terms of service, my parents are my biggest role models and have always encouraged me to give back to my community,” shared Ghoneim, who studied neuroscience and pharmacology senior year, seeking to cultivate her passions and see where they would lead. “I never considered conducting my own research past middle school science fairs. It wasn’t until I learned just how much there was still to discover that I truly recognized it as a possible career. After my first experience in a lab studying cancer, my passion for scientific research and growing curiosity spurred me to find my next placement and motivated me to apply for the Beckman Scholars Program.” Ghoneim’s Beckman-funded research took place in the lab of Dr. Linda Van Eldik and involved the study of the brain, Alzheimer’s disease, and its associated inflammation. Alzheimer’s disease is the seventh-leading cause of death in the United States and the most common cause of dementia among older adults. There is no cure; current treatments focus on slowing progression of the disease. The lab developed a small molecule drug compound, MW151, that was found to suppress abnormal neuroinflammatory responses and protect the nerve cells. The mechanism of action of the drug, however, was still unknown and past experiments raised the possibility that modulation of cellular metabolism could be involved in curtailment of inflammatory responses. Ghoneim aimed to explore that possibility by testing the hypothesis that MW151 exerts anti-inflammatory effects via inhibition of induced glycolysis known to occur in myeloid cells in response to inflammatory activation. Her own description of the project: Challenging, but invigorating. Understanding the mechanism of action of MW151 could help maximize the odds of clinical success and spur the development of additional compounds that are efficacious not just for Alzheimer’s disease, but also for other neurodegenerative conditions. Read more: https://ow.ly/eNPk50U2LEC University of Kentucky #beckman #fridayfeature #article #interview #science #research #alzheimers #brain #medicine #community #mentorship #undergraduateresearch #BSP #beckmanscholars #gradschool #futureMD #careers #academicjourneys

The 2nd Annual Research Symposium was recently held. Special thanks to the 117 students who submitted abstracts and everyone who made this event a success. Congrats to this year’s winner, Shakhzoda Alimdjanova, on her project titled “Upregulation of T-Cell Exhaustion in Pre-Liver Transplant Recipients at High Risk for Persistent Post-Transplant Immune Dysfunction and Mortality.” The top three selected abstracts include: Joshua Ballway (Class of 2025, 3rd year medical student): • Category for submission: Innovation • Title: “Characterizing Immune Cell Subsets in Blastic Plasmacytoid Dendritic Cell Neoplasm: Roadmaps to Therapies and Discerning Immune Subset Differentiation” Rhema Dadala (Class of 2027, 1st year medical student): • Category for submission: Basic Science • Title: “Effect of Probiotic Associated Metabolites on the Gut Barrier” Shakhzoda Alimdjanova (Class of 2026, 2nd year medical student): • Category for submission: Basic Science • Title: “Upregulation of T-Cell Exhaustion in Pre-Liver Transplant Recipients at High Risk for Persistent Post-Transplant Immune Dysfunction and Mortality” #RutgersNJMS

📰 The news is out! Cancer Research UK Science and Innovation is launching a brand new clinical research funding scheme. This September, the new initiative will replace all current clinical funding schemes, enabling researchers to investigate bold and innovative ways to develop kinder and more effective treatments. Together we are beating cancer. Find out more 👇 #ClinicalResearch #Funding #CancerResearch 

In the realm of clinical research, blinding is not just a concept—it's a cornerstone of integrity. 🛡️ From single-blind to the gold standard double-blind, and the comprehensive triple-blind, each method plays a pivotal role in ensuring unbiased results. Let's explore the nuances of blinding and why it's indispensable for credible studies. #ClinicalResearch #Blinding #MedicalScience #Innovation

Meet Dr. Shilpa Hattangadi, a pediatric hematologist and program director at NIDDK. From overseeing programs in hematopoiesis, which is the production and function of blood cells, to empowering the next generation of researchers, Dr. Hattangadi is making waves in the field of biomedical research. "The beauty of research is that it never ends. The right kinds of studies uncover more questions. The best studies create immediate questions for the next ten years as well as the foundation for entire future whole fields." Read more about her professional journey in the latest Director's Update. https://lnkd.in/duQRMMXw #DKupdate

As our first post, we’d like to introduce our project: ‘From Cell Being to Well Being' 🧬 We are a team of 10 students from the FHML Honours Program at Maastricht University 🎓 Our project's focus is Marfan's Syndrome: a genetic condition that impacts connective tissue, causing widespread effects, particularly on the heart, eyes, and skeleton. →  Weakened connective tissue can lead to Thoracic Aortic Aneurysm (TAA), significantly increasing the risk of aortic dissection and heart-related complications 🫀 Our team comes from different bachelor degrees at FHML, being either Biomedical Science, Health Science, or Medicine.  Our goal? To enhance the way Marfan Syndrome is understood, focusing on enhancing scientific communication and creating stronger connections among researchers, health care professionals, and, most importantly, patients 🏥 By breaking down complex scientific concepts into simple insights, we ensure that those affected by Marfan Syndrome are not just informed, but empowered💪🏼 We are committed to creating a platform where knowledge flows freely, and every voice is heard, from the lab bench to the bedside.🥼🔬🧑💼 Daniela Olinic Thijs Hahn Carlynn Felice Luca Hounjet Jodi Orban Radu Dumbraveanu Sophie Ramjoie Luisa Akansu Fleur Post Nika Cindori #MarfanSyndrome #ScientificCommunication #BridgingGaps #FromCellBeingToWellBeing